These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7833591)

  • 1. Changes in the renin-angiotensin-aldosterone axis in later life.
    Belmin J; Lévy BI; Michel JB
    Drugs Aging; 1994 Nov; 5(5):391-400. PubMed ID: 7833591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology.
    Mochel JP; Fink M; Peyrou M; Desevaux C; Deurinck M; Giraudel JM; Danhof M
    Chronobiol Int; 2013 Nov; 30(9):1144-59. PubMed ID: 23931032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
    Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W
    Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between urinary sodium excretion and serum aldosterone in patients with diabetes in the presence and absence of modifiers of the renin-angiotensin-aldosterone system.
    Libianto R; Jerums G; Lam Q; Chen A; Baqar S; Pyrlis F; Macisaac RJ; Moran J; Ekinci EI
    Clin Sci (Lond); 2014 Jan; 126(2):147-54. PubMed ID: 23875766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss and the renin-angiotensin-aldosterone system.
    Engeli S; Böhnke J; Gorzelniak K; Janke J; Schling P; Bader M; Luft FC; Sharma AM
    Hypertension; 2005 Mar; 45(3):356-62. PubMed ID: 15630041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function.
    Ho JT; Keogh JB; Bornstein SR; Ehrhart-Bornstein M; Lewis JG; Clifton PM; Torpy DJ
    Horm Metab Res; 2007 Sep; 39(9):694-9. PubMed ID: 17846979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
    Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression.
    Verdonk K; Saleh L; Lankhorst S; Smilde JE; van Ingen MM; Garrelds IM; Friesema EC; Russcher H; van den Meiracker AH; Visser W; Danser AH
    Hypertension; 2015 Jun; 65(6):1316-23. PubMed ID: 25870197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.
    Martinez J; Kellogg C; Iazbik MC; Couto CG; Pressler BM; Hoepf TM; Radin MJ
    J Vet Intern Med; 2017 Jul; 31(4):988-993. PubMed ID: 28488321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
    Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J
    J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.